Fortrea Holdings (FTRE) FCF Margin (2022 - 2026)
Fortrea Holdings' (FTRE) quarterly FCF Margin came in at 2.93% in Q2 2026, up 92.0% on a YoY basis from 1.53% in Q2 2025, and up 174.71% quarter-over-quarter from 3.93% in Q1 2026.
Powered by 
Analysis
Fortrea Holdings (FTRE) FCF Margin (2022 - 2026) Analysis & Trends
Fortrea Holdings (FTRE) has reported FCF Margin for 5 consecutive years, with 2.93% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, FCF Margin rose 92.0% year-over-year to 2.93%; the trailing twelve-month figure through Jun 2026 stood at 7.32% (up 1109.0% YoY), and the FY2025 full-year result was 3.24%, down 556.0% from the prior year.
- FCF Margin grew to 2.93% in Q2 2026 per FTRE's latest filing, from 3.93% in the prior quarter.
- Across five years, FCF Margin topped out at 39.63% in Q2 2024 and bottomed at 19.51% in Q1 2025.
- Historically, FCF Margin has averaged 4.62% across 5 years, with a median of 1.64% in 2023.
- The sharpest annual moves came in 2024 and 2025: FCF Margin jumped 2025 bps in 2024, then sank 3762 bps in 2025.
- Over 5 years, FCF Margin stood at 1.01% in 2022, then rose by 25 bps to 1.27% in 2023, then soared by 130 bps to 2.91% in 2024, then surged by 532 bps to 18.41% in 2025, then slumped by 84 bps to 2.93% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 2.93%, 3.93%, and 18.41% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.77 Bn | 40.69 Bn | 1.44 Bn | 8.24% |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 19.52% |
| 3 | Charles River Laboratories International | 13.37 Bn | 13.18 Bn | 452.07 Mn | 14.80% |
| 4 | Icon | 12.49 Bn | 11.56 Bn | 479.29 Mn | 15.69% |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn | 2.93% |
| 6 | Evotec SE | 642.83 Mn | 216.96 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 422.55 Mn | 338.02 Mn | 18.44 Mn | -232.65% |
| 8 | Champions Oncology | 69.16 Mn | 69.16 Mn | 7.03 Mn | -16.17% |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn | -58.25% |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - | -17,977.78% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.93% |
| Mar 31, 2026 | -3.93% |
| Dec 31, 2025 | 18.41% |
| Sep 30, 2025 | 11.34% |
| Jun 30, 2025 | 2.01% |
| Mar 31, 2025 | -19.51% |
| Dec 31, 2024 | 2.91% |
| Sep 30, 2024 | -1.57% |
| Jun 30, 2024 | 39.63% |
| Mar 31, 2024 | -5.27% |
| Dec 31, 2023 | 1.27% |
| Sep 30, 2023 | -0.45% |
| Jun 30, 2023 | 19.38% |
| Mar 31, 2023 | -2.62% |
| Dec 31, 2022 | 1.01% |
| Sep 30, 2022 | 8.38% |